Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tempus AI, Inc. - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
TEM
Nasdaq
8071
www.tempus.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tempus AI, Inc.
Dow Jones Futures: S&P 500 Hits High As Astera, GE Vernova, Arista Lead Buys, But These Stocks Tumble
- Oct 6th, 2026 6:55 pm
Fortune Unveils the "Fortune Future 120" 2026 List
- Oct 6th, 2026 6:00 am
Tempus AI (TEM) Shares Just Moved, So What Is Going On?
- Oct 5th, 2026 11:07 pm
Here's How Tempus AI is Capitalizing on AI-ECG Market Growth
- Oct 5th, 2026 8:03 am
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
- Oct 1st, 2026 10:11 am
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
- Oct 1st, 2026 6:34 am
Cathie Wood Sold $110 Million of AMD and Bought Nvidia Instead
- Sep 30th, 2026 7:16 am
Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board
- Sep 29th, 2026 5:00 am
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
- Sep 28th, 2026 6:00 am
Tempus AI Chief Accounting Officer Sells $529,650 of Stock
- Sep 24th, 2026 7:00 am
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4
- Sep 24th, 2026 4:22 am
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test
- Sep 22nd, 2026 2:48 pm
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
- Sep 21st, 2026 6:02 pm
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
- Sep 21st, 2026 7:14 am
Tempus AI (TEM) Is Building a Heart Failure Agent That Never Sleeps
- Sep 20th, 2026 10:33 pm
Tempus AI (TEM), What Is Behind The Latest Buzz?
- Sep 19th, 2026 11:12 pm
Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative
- Sep 19th, 2026 10:12 am
Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes
- Sep 19th, 2026 5:14 am
Scroll